» Articles » PMID: 19801547

Calnexin Improves the Folding Efficiency of Mutant Rhodopsin in the Presence of Pharmacological Chaperone 11-cis-retinal

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2009 Oct 6
PMID 19801547
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

The lectin chaperone calnexin (Cnx) is important for quality control of glycoproteins, and the chances of correct folding of a protein increase the longer the protein interacts with Cnx. Mutations in glycoproteins increase their association with Cnx, and these mutant proteins are retained in the endoplasmic reticulum. However, until now, the increased interaction with Cnx was not known to increase the folding of mutant glycoproteins. Because many human diseases result from glycoprotein misfolding, a Cnx-assisted folding of mutant glycoproteins could be beneficial. Mutations of rhodopsin, the glycoprotein pigment of rod photoreceptors, cause misfolding resulting in retinitis pigmentosa. Despite the critical role of Cnx in glycoprotein folding, surprisingly little is known about its interaction with rhodopsin or whether this interaction could be modulated to increase the folding of mutant rhodopsin. Here, we demonstrate that Cnx preferentially associates with misfolded mutant opsins associated with retinitis pigmentosa. Furthermore, the overexpression of Cnx leads to an increased accumulation of misfolded P23H opsin but not the correctly folded protein. Finally, we demonstrate that increased levels of Cnx in the presence of the pharmacological chaperone 11-cis-retinal increase the folding efficiency and result in an increase in correct folding of mutant rhodopsin. These results demonstrate that misfolded rather than correctly folded rhodopsin is a substrate for Cnx and that the interaction between Cnx and mutant, misfolded rhodopsin, can be targeted to increase the yield of folded mutant protein.

Citing Articles

Preclinical dose response study shows NR2E3 can attenuate retinal degeneration in the retinitis pigmentosa mouse model Rho.

McNamee S, Chan N, Akula M, Avola M, Whalen M, Nystuen K Gene Ther. 2024; 31(5-6):255-262.

PMID: 38273095 PMC: 11090815. DOI: 10.1038/s41434-024-00440-6.


Network biology analysis of P23H rhodopsin interactome identifies protein and mRNA quality control mechanisms.

Kim K, Safarta L, Chiang W, Coppinger J, Lee E, Lin J Sci Rep. 2022; 12(1):17405.

PMID: 36258031 PMC: 9579138. DOI: 10.1038/s41598-022-22316-8.


Structure network-based landscape of rhodopsin misfolding by mutations and algorithmic prediction of small chaperone action.

Felline A, Schiroli D, Comitato A, Marigo V, Fanelli F Comput Struct Biotechnol J. 2021; 19:6020-6038.

PMID: 34849206 PMC: 8605067. DOI: 10.1016/j.csbj.2021.10.040.


Structural aspects of rod opsin and their implication in genetic diseases.

Fanelli F, Felline A, Marigo V Pflugers Arch. 2021; 473(9):1339-1359.

PMID: 33728518 DOI: 10.1007/s00424-021-02546-x.


Nr2e3 is a genetic modifier that rescues retinal degeneration and promotes homeostasis in multiple models of retinitis pigmentosa.

Li S, Datta S, Brabbit E, Love Z, Woytowicz V, Flattery K Gene Ther. 2020; 28(5):223-241.

PMID: 32123325 PMC: 7483267. DOI: 10.1038/s41434-020-0134-z.


References
1.
Warrick J, Chan H, Chai Y, Paulson H, Bonini N . Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nat Genet. 1999; 23(4):425-8. DOI: 10.1038/70532. View

2.
Gong Q, Jones M, Zhou Z . Mechanisms of pharmacological rescue of trafficking-defective hERG mutant channels in human long QT syndrome. J Biol Chem. 2005; 281(7):4069-74. PMC: 1624912. DOI: 10.1074/jbc.M511765200. View

3.
Mu T, Ong D, Wang Y, Balch W, Yates 3rd J, Segatori L . Chemical and biological approaches synergize to ameliorate protein-folding diseases. Cell. 2008; 134(5):769-81. PMC: 2650088. DOI: 10.1016/j.cell.2008.06.037. View

4.
Leskela T, Markkanen P, Pietila E, Tuusa J, Petaja-Repo U . Opioid receptor pharmacological chaperones act by binding and stabilizing newly synthesized receptors in the endoplasmic reticulum. J Biol Chem. 2007; 282(32):23171-83. DOI: 10.1074/jbc.M610896200. View

5.
Esapa C, McIlhinney R, Blake D . Fukutin-related protein mutations that cause congenital muscular dystrophy result in ER-retention of the mutant protein in cultured cells. Hum Mol Genet. 2004; 14(2):295-305. DOI: 10.1093/hmg/ddi026. View